Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients. (Q51905830)
Jump to navigation
Jump to search
scientific article published on 14 September 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients. |
scientific article published on 14 September 2007 |
Statements
Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients. (English)
1 reference
1 reference
Anders Larsson
1 reference
Dorthe Hellemann
1 reference
Hans O Madsen
1 reference
Jan Bonde
1 reference
Jens Otto Jarløv
1 reference
Jørgen Wiis
1 reference
Torsten Faber
1 reference
14 September 2007
1 reference
16
1 reference
24
1 reference
3071-3080
1 reference
Identifiers
1 reference